Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis

BACKGROUND: This study aimed to investigate the efficacy of prophylactic amifostine in reducing the risk of severe radiation colitis in cancer patients receiving radical radiotherapy to the pelvis. METHODS: Patients with pelvic tumours referred for radical radiotherapy who consented participation in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Katsanos, Konstantinos H, Briasoulis, Evangelos, Tsekeris, Pericles, Batistatou, Anna, Bai, Maria, Tolis, Christos, Capizzello, Antonio, Panelos, Ioannis, Karavasilis, Vasileios, Christodoulou, Dimitrios, Tsianos, Epameinondas V
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903531/
https://ncbi.nlm.nih.gov/pubmed/20537164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-29-68
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars